Second Field Tumors: A New Opportunity for Cancer Prevention?

Second Field Tumors: A New Opportunity for Cancer Prevention? Boudewijn J.M. Braakhuis, Ruud H. Brakenhoff, C. René Leemans Oncologist 2005; 10: 493-500 Author Information and Disclosures Target Audience: Physicians who wish to advance their current knowledge of clinical cancer medicine in head and neck cancers and are involved in providing patient care in a cancer care environment. Method of Physician Participation: Read course materials, complete course quiz and evaluation form (optional). Learning Objectives After completing this course, the reader should be able to: Describe the origin and clinical burden of HNSCC. Explain the concept of field malignancy. Discuss the potential of prevention research in HNSCC. The NIH/FAES designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CME Activity Information Accreditation CME Instructions For Credit Privacy Statement Hardware/Software Requirements Release Date: Aug. 03, 2005 Most Recent Review: Aug. 03, 2005* Most Recent Update: Aug. 03, 2005 Date Credit Expires: Aug. 03, 2007 Time to Complete: 1 hour Medium: Internet Online *Click here to learn more about our review process.